Optimization of Automated Synthesis of 2-[18F]Fluoro-2-deoxy-D-glucose Involving Base Hydrolysis

Institute of Human Brain
Radiochemistry 06/2002; 44(4):403-409. DOI: 10.1023/A:1020689314452

ABSTRACT Synthesis of 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) involving base hydrolysis was optimized. Fluorine-18 was isolated from irradiated water to more than 90% by sorption of [1
8F]fluoride on QMA anion-exchange resin, which was followed by elution with a 96 : 4 (by volume) acetonitrile-water mixture containing Kryptofix 2.2.2 and potassium carbonate (molar ratio 2 : 1). This composition is the best for preparing the complex [K/K2.2.2]+
18F- used in nucleophilic fluorinations. No additional azeotropic drying is required. Base hydrolysis under optimized conditions (40-45C), followed by neutralization with HCl, removal of traces of the solvent, and purification of the final product on a combined SCX/Alumina N column, yielded [1
8F]FDG of high radiochemical (>99%) and chemical purity with minimal product loss. With an RB-86 robotic system (Anatech, Sweden), the synthesis time was 38 min. The procedure is used in the Institute of Human Brain, Russian Academy of Sciences for routine synthesis of FDG; the radiochemical yield of the product by the end of synthesis (EOS) is reproducibly high: 633% (n = 40).

  • [Show abstract] [Hide abstract]
    ABSTRACT: A novel fully automated radiosynthesis procedure for the fluorine-18 analog of 1-alpha-D-(5'-deoxy-5'-fluoro-(1S,2R,3S,4S) arabinofuranosyl)-2-nitroimidazole ([(18)F]FAZA) using a commercially available combination column - Chromabond Set V (FDG-base-hydrolysis) - for purification was developed. [(18)F]FAZA was prepared via a one-pot, two-step synthesis using a nuclear interface nucleophilic synthesis module. Nucleophilic fluorination of the precursor molecule, 1-(2,3-di-O-acetyl-5-O-tosyl-alpha-D-arabinofuranosyl)-2-nitroimidazole, with no-carrier added [(18)F]fluoride followed by hydrolysis of the protecting groups with 0.3M NaOH was performed. Purification was carried out using the Chromabond Set V column without any modifications. The overall radiochemical yield obtained was 21.98+/-1.40% (n=5, without decay correction) within a total synthesis period of 51+/-1 min. The radiochemical purity was greater than 95% and devoid of any other chemical impurities. The reported method can easily be adapted in any commercial FDG synthesis module.
    Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture, industry and medicine 10/2010; 68(10):1944-9. DOI:10.1016/j.apradiso.2010.04.011 · 1.06 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: The diagnosis of infection and the ability to distinguish bacterial infection from nonbacterial inflammation by positron emission tomography (PET) have gained interest in recent years, but still few specific radiopharmaceuticals are available for use. In this study, we developed a new radiosynthesis method of 2-deoxy-2-[18F]fluoroacetamido-D-glucopyranose ([18F]FAG) by applying microwave irradiation and demonstrated that [18F]FAG could be a potential radiopharmaceutical to distinguish bacterial infection from nonbacterial inflammation. Methods: 1,3,4,6-Tetra-O-acetyl-2-deoxy-2-bromoacetamido-D-glucopyranose was used as precursor, and labeling was performed under microwave irradiation conditions followed by alkaline hydrolysis and high-performance liquid chromatography (HPLC) purification. In vitro uptake of [18F]FAG by Escherichia coli was performed. Tissue biodistribution of [18F]FAG was performed in mice. Moreover, PET imaging acquisition of E. coli infection and nonbacterial inflammation models was performed in rats. Tissue radiotracer-accumulated sites were analyzed by hematoxylin and eosin staining and anti–E.coli immunostaining. Results: The radiosynthesis of [18F]FAG was achieved with microwave irradiation, and the radiochemical yield was 9.7%±2.8% end of bombardment (EOB); the radiochemical purity was more than 98%, and the total synthesis time was 62 min. Compared with control group, in vitro uptake of [18F]FAG by E. coli was significantly decrease in inhibition group (Pb.05). Biodistribution studies in mice showed rapid clearance of [18F]FAG from the animal body. [18F]FAG clearly visualized the infection areas but not nonbacterial inflammation areas in PET studies. Quantitative analysis revealed that the uptake of [18F]FAG into infection areas was significantly higher than that of [18F]FAG into inflammation areas (Pb.05). Histological analysis demonstrated the presence of bacterial cells at the sites of accumulation of [18F]FAG. Conclusions: Using 1,3,4,6-tetra-O-acetyl-2-deoxy-2-bromoacetamido-D-glucopyranose as a precursor, the new radiosynthesis method of [18F]FAG was achieved in fewer steps and with a shorter synthesis time than previously reported. Furthermore, [18F]FAG was able to distinguish bacterial infection from nonbacterial inflammation.
    Nuclear Medicine and Biology 07/2011; DOI:10.1016/j.nucmedbio.2011.02.006 · 2.41 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to develop a direct fluorination method for the preparation of [18F]-(E)-N-(3-iodoprop-2-enyl)-2β-carbofluoroethoxy-3β-(4′-methyl-phenyl)nortropane ([18F]FE-PE2I (VI). The synthesis procedure relies on the conventional Kryptofix-mediated nucleophilic 18F-substitution of the tosylate group in the precursor, TsOE-PE2I (V). Out of reaction conditions tested, the highest fluorination efficiency was obtained in dimethyl sulfoxide at 140°C. The reaction mixture was purified by semi-preparative HPLC, followed-up by a standard Sep-Pak SPE procedure. On average, 1.0 GBq of [18F]FE-PE2I was produced from 5-min irradiation at 35 μA (dimethyl sulfoxide, 5 min/140°C). Decay-uncorrected yield of the product after HPLC purification and formulation was in the order of 20%. Specific radioactivity of [18F]FE-PE2I at 15 min after EOS was 3.3–5.1 Ci/µmol (n = 3); radiochemical purity was >98% (n = 4). This direct nucleophilic fluorination strategy is well suited for the automation of the entire synthesis of [18F]FE-PE2I in a modern PET synthesizer for human PET application. In addition, the 18F-incorporation rate into TsOE-PE2I was evaluated using radio-thin layer chromatography (TLC) and radio-HPLC. The suggested HPLC method (ACE 5 C18-HL column and acetonitrile/0.1 M NH4CO2 (80:20)) was found to be suitable for evaluation of ‘free’ 18F-fluoride in the reaction mixture; in addition, this method allowed the detection of three radiolabelled by-products that were not discernable with the TLC approach. Therefore, we conclude that the HPLC approach may serve as a good alternative to traditional radio-TLC technique as it provides more detailed information about the fluorination process in the reaction kinetics or optimization studies.
    Journal of Labelled Compounds and Radiopharmaceuticals 05/2012; 55(6):206-210. DOI:10.1002/jlcr.2927 · 1.19 Impact Factor


Available from
Nov 10, 2014